Juror Analyticals & Research Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 100.49%
- Profit Growth -35.00%
- Ebitda -102.20%
- Net Worth 0.01%
- Total Assets 0.01%
About Juror Analyticals & Research
Juror Analyticals & Research Private Limited (JARPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 May 2016 (Eight years and eight months 15 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Tapan Sharma and Naman Sharma serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MP2016PTC040769
-
Company No.
040769
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 May 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Juror Analyticals & Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tapan Sharma
|
Director | 17-May-2016 | Current |
|
Naman Sharma
|
Director | 17-May-2016 | Current |
Financial Performance of Juror Analyticals & Research.
Juror Analyticals & Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 100.49% increase. The company also saw a substantial fall in profitability, with a 35% decrease in profit. The company's net worth moved up by a moderate rise of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Juror Analyticals & Research?
In 2023, Juror Analyticals & Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rusoma Laboratories Private LimitedTapan Sharma and Naman Sharma are mutual person
-
Rumoya Healthcare LlpTapan Sharma and Naman Sharma are mutual person
-
Rusoma Lifesciences Private Limited
Tapan Sharma and Naman Sharma are mutual person
-
Agir Lifesciences Private Limited
Tapan Sharma is a mutual person
-
Rusoma Healthcare Private Limited
Tapan Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Juror Analyticals & Research?
Unlock and access historical data on people associated with Juror Analyticals & Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Juror Analyticals & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Juror Analyticals & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.